ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BeyondSpring Announces U.S. FDA Acceptance And Priority Review Of New Drug Application For Plinabulin And G-CSF Combination For The Prevention Of Chemotherapy-Induced Neutropenia (CIN)
June 21, 2021BeyondSpring Inc. today announced that the FDA has accepted for filing, and with Priority Review, the Company’s NDA seeking approval for use of plinabulin in combination with granulocyte colony-stimulating factor -
Mundipharma’s Neulasta biosimilar approved in EU
March 07, 2019A second cut-price biosimilar of Amgen’s Neulasta (pegfilgrastim) long-acting white blood cell booster is to hit the EU market after the European Commission approved Mundipharma’s Pelmeg.
Pharma Sources Insight January 2025
